Searched for
MOLBIO DIAGNOSTICS LISTING
Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?Molbio Diagnostics IPO entered its final bidding day with strong demand, with the Rs 939.70-crore issue subscribed 4.91 times. Its GMP has ...- Molbio Diagnostics IPO Day 2: GMP hits at 17% listing gains. Should you bid?Molbio Diagnostics IPO GMP: The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GM...
- Dhoot, Milky Mist or Molbio? What should investors pick in Rs 7,000 crore IPO rush this weekThis week, India's IPO market shines brightly as five firms successfully raise over Rs 7,000 crore. Analysts highlight Dhoot Transmission a...
- Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broad...
- Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?Molbio Diagnostics aims to secure ₹200 crore to enhance its capital expenditures through a new issuance of shares. In tandem, the firm inte...
- World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor roundMolbio Diagnostics raised Rs 281 crore from anchor investors, including World Bank Group's IFC and HDFC Mutual Fund, ahead of its Rs 940 cr...
- Rs 7,681 crore IPO rush: Shiprocket, Milky Mist among 9 issues to hit the marketIndia’s primary market is set for a busy week, with nine companies aiming to raise a combined Rs 7,681 crore through IPOs across the mainbo...
- Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPOMolbio Diagnostics has successfully attracted Rs 281.5 crore from anchor investors ahead of its much-anticipated initial public offering. T...
- Pharma, healthcare firms eye Rs 13,000-cr IPO wave over 9 monthsIndian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs i...
- CXOs log out of unicorns to start up own venturesA large number of top executives have moved from unicorns to Series A and B firms or even down the chain in recent months – a move that ref...
- Cyient DLM shares list at a healthy premium. Should you hold or sell?"We continue to advise allotted investors to book profits, and if anyone wishes to buy, they should wait and watch for the counter as marke...
- Solid Start! Cyient DLM shares list at 52% premium over IPO priceIntegrated electronic manufacturing services provider Cyient DLM made a strong debut on the stock exchanges, with shares listing at a premi...
- After ideaForge's listing pop, will Cyient DLM follow suit? Here's what GMP signalsThe grey market premium (GMP) of Cyient DLM is around Rs 150-155 in the unlisted market. If we consider the upper price band of Rs 265, the...
- Cyient DLM IPO continues to garner strong interest on Day 2; issue subscribed 7.6 timesCyient DLM's initial public offering (IPO) received a strong response as the overall issue was subscribed 7.6 times. The retail category ha...
- Cyient DLM IPO opens. Should you subscribe to the issue?Cyient DLM has initiated its initial public offering for subscription, with a price band of INR250-265 ($3.36-$3.55) and a proposed market ...
- Cyient DLM chip off a known block, needs time to scale upListed IT company Cyient is the promoter of the company. Given the rich valuation, high risk-taking investors may consider the IPO to parti...
- SaaS pips fintech as largest unicorn creator in 2022: Orios Venture reportHowever, many of the SaaS unicorns reached the coveted $1-billion valuation on the back of inflated price-to-valuation ratios, Orios managi...
Load More
